Upcoming Zepto IPO: From Singapore to India; Key approvals and shifts – Here’s what you need to know

Zepto, another rapidly growing quick commerce platform, is gearing up to make its entry on the Indian stock market with an upcoming IPO. This recent development comes after a series of approvals and decisions, paying way for the company to transition back to India from Singapore.

Here are the key details surrounding this development: Strategic Merger to Simplify Structure

Zepto’s parent company, Kiranakart Technologies, recently received approval from the National Company Law Tribunal (NCLT) for a merger with its Singapore-based entity. On the one hand, this move simplifies the company in the process of attracting investors both from India and abroad as well as it streamlines Zepto’s corporate structure, making it more efficient for future funding and operations.

The Domicile Shift

Another key development to note is Zepto shifting its domicile from Singapore to India, a transition that is expected to be finalised within the next 30 days. This will help the quick commerce company to come more closer to Indian markets.

As the company prepares for its IPO, this move also positions the company to attract domestic investors.

Also Read: Markets end in green but tech under pressure, Nifty IT Index slumps 2%; rupee slips to yet another new low 

Regulatory approval

One of the major and key highlights in this development is the approval of the merger without the need for a no-objection certificate from the RBI. This eliminates one major regulatory step for Zepto, speeding up the process and allowing the company to focus on other aspects of its IPO preparation.

Zepto’s IPO timeline and draft filing plans

As per reports, the quick commerce company Zepto is planning to file its draft IPO papers by March or April but the company has not yet disclosed anything officially. A key board meeting on January 19 will help finalise important details, such as the appointment of investment bankers and independent directors, and determine the size of the IPO.

Zepto’s fundraising plan

The company is aiming to raise between USD 400 million and USD 500 million through its IPO, as per various reports.

Furthermore, the funds will help Zepto compete with major players like Swiggy and Zomato, who have already paved the way for food delivery platforms to go public.

Operational changes

In addition to its IPO plans,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth